(UR) United States — There is only one reason why the U.S. Food and Drug Administration (FDA) hasn’t banned the sale of super-healing, cannabis-based oils when both hemp and marijuana are still on the Feds Schedule I list — it’s because a major pharmaceutical company is interested in marketing CBD.
FDA Doesn’t Recognize CBD as a ‘Legal’ Food
What is odd is that FDA has not officially recognized CBD, short for cannabidiol, a non-psychoactive variety of Cannabis sativa and a relative of tetrahydrocannabinol (THC), as a legal dietary ingredient. It is being used heavily in medical marijuana circles and as a dietary supplement since cannabis is full of healthy plant compounds — more than 400 have been named, though only 61 are actually cannabinoids.
One of them, delta-9-tetrahydrocannabinol (THC), was isolated and synthesized in 1964 and is clearly the most pharmacologically active. This is likely the chemical compound which drug companies are rushing to patent in a synthetic form, and also why the FDA has yet to ban CBD.
Cannabis Users are Giving Up Prescription Drugs in Droves
Most interesting, too, is the recent discovery that 80 percent of cannabis users have given up their prescription pills. With a near 5,000 year history of healing everything from epileptic seizures to leprosy and incontinence, it’s no wonder that Big Pharma wants its cut of the pot scene.
The warnings issued to makers of legal CBD products by the FDA warned them that they could not market the oils in a certain manner: calling them a “medical cure.”
These FDA warnings also called out companies that were selling CBD oil which contained hardly any cannabis. Other questionable claims were also reprimanded. This still is not the reason that hemp-based oils have yet to be banned by the FDA, while major drug raids are still taking place all over the nation.
In a major correction to an article that was shared nearly 100,000 times on Facebook, Mike Adams said that his title, “FDA just outlawed CBDs and hemp oil extracts by claiming all plant molecules now belong exclusively to Big Pharma,” was a bit misleading, but his sentiment is not wrong.
In fact, the FDA is writing its own regulatory laws to try to leave room for major drug companies to patent one of the most medically promising plants this planet has seen in several centuries.
- GW Pharmaceuticals announced that it has been issued a Notice of Allowance from the U.S. Patent Office for a patent application involving the use of THC and CBD, the two main chemicals in marijuana, for treating a form of cancer.
- A U.S. patent has even been issued for cannabinoid chewing gum.
- Our own government owns a patent on cannabis. Patent number 6,630,507 states unequivocally that cannabinoids are useful in the prevention and treatment of a wide variety of diseases including autoimmune disorders, stroke, trauma, Parkinson’s, and Alzheimer’s and HIV dementia. That patent, awarded in 2003, is based on research done by the National Institute of Health and is assigned to the U.S. Dept. of Health and Human Services, even though the Federal government states that medical marijuana has no “currently accepted medical use.”
Pharmaceutical companies are well versed in the loopholes of patent law that can easily be exploited by slightly altering a chemical or formula.
You can bet that as soon as they find a way to genetically manipulate a cannabis plant to bow to their own whims, then Big Pharma will sell us all fake pot for astronomical prices. The FDA always has Big Pharma’s and biotech’s back — it’s a pharmaceutical racketeering love triangle. That’s why even though CBD hasn’t been banned, it does offer a new way to fleece the unaware.
This article (Hoax: Viral Cannabis Oil Article Is Exactly Why You Need to Do Your Own Research) is free and open source. You have permission to republish this article under a Creative Commons license with attribution to Christina Sarich and UndergroundReporter.org. If you spot a typo, please email the error and the name of the article to firstname.lastname@example.org. Image credit: Pixabay